Off-label Use of Recombinant Activated Factor VII for Cardiac Surgical Bleeding

被引：4
|
作者：
Flynn, Brigid C. [1 ,4 ]
Steiner, Marie E. [2 ]
Mazzeffi, Michael [3 ]
机构：
[1] Univ Kansas, Dept Anesthesiol, Med Ctr, Kansas City, KS USA
[2] Univ Minnesota, Div Hematol Oncol & Crit Care, Minneapolis, MN USA
[3] Univ Virginia, Dept Anesthesiol, Sch Med, Charlottesville, VA USA
[4] Univ Kansas, Dept Anesthesiol, Med Ctr, Kansas City, KS 66160 USA
来源：
ANESTHESIOLOGY | 2023年 / 139卷 / 02期
关键词：
BLOOD-CELL TRANSFUSIONS; ACUTE AORTIC DISSECTION; INTRAOPERATIVE USE; DOUBLE-BLIND; SURGERY; SAFETY; NOVOSEVEN(R); MANAGEMENT; EFFICACY; RFVIIA;
D O I：
10.1097/ALN.0000000000004569
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
This review discusses the history and present-day off-label use of recombinant activated factor VII for cardiac surgical bleeding.
引用
收藏
页码：197 / 210
页数：14
相关论文
共 50 条
  • [1] Off-Label Use of Recombinant Activated Factor VII -- Safe or Not Safe?.
    Aledort, Louis M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19): : 1853 - 1854
  • [2] Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery
    Karkouti, Keyvan
    Beattie, W. Scott
    Arellano, Ramiro
    Aye, Tim
    Bussieres, Jean S.
    Callum, Jeannie L.
    Cheng, Davy
    Heinrich, Lee
    Kent, Blaine
    Lee, Trevor W. R.
    MacAdams, Charles
    Mazer, C. David
    Muirhead, Brian
    Rochon, Antoine G.
    Rubens, Fraser D.
    Sawchuk, Corey
    Wang, Shaohua
    Waters, Terrence
    Wong, Bill I.
    Yau, Terrence M.
    [J]. CIRCULATION, 2008, 118 (04) : 331 - 338
  • [3] Review of the Off-Label Use of Recombinant Activated Factor VII in Pediatric Cardiac Surgery Patients
    Guzzetta, Nina A.
    Russell, Isobel A.
    Williams, Glyn D.
    [J]. ANESTHESIA AND ANALGESIA, 2012, 115 (02): : 364 - 378
  • [4] Off-label use of recombinant activated factor VII (rFVIIa) in children.
    Punzalan, RC
    Ghanayem, NS
    Gill, JC
    Jaquiss, RDB
    Montgomery, RR
    Gottschall, JL
    [J]. BLOOD, 2003, 102 (11) : 137B - 137B
  • [5] Off-label use of recombinant activated coagulation factor VII for bleeding may raise the risk of arterial thrombosis
    Laura Ferrari
    Gian Marco Podda
    [J]. Internal and Emergency Medicine, 2011, 6
  • [6] Off-label use of recombinant activated coagulation factor VII for bleeding may raise the risk of arterial thrombosis
    Ferrari, Laura
    Podda, Gian Marco
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2011, 6 (03) : 261 - 262
  • [7] SAFETY AND EFFICACY OF OFF-LABEL USE OF RECOMBINANT ACTIVATED FACTOR VII IN CARDIOTHORACIC SURGERY
    Walla, Danielle
    Johnson, Manda
    Baek, Grace
    Schanz, Caitlin
    Pham, Lily
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [8] Recombinant Activated Factor VII: The Controversial Conundrum Regarding Its Off-Label Use
    Karkouti, Keyvan
    Levy, Jerrold H.
    [J]. ANESTHESIA AND ANALGESIA, 2011, 113 (04): : 711 - 712
  • [9] Caution with the published database reviews analyzing the off-label use of recombinant activated factor VII (rFVIIa) in cardiac surgery
    Al-Ruzzeh, Sharif
    Navia, Jose L.
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2010, 43 (02) : 245 - 246
  • [10] Evaluation of off-label recombinant activated factor VII for multiple indications in children
    Reiter, Pamela D.
    Valuck, Robert J.
    Taylor, Rustorl S.
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2007, 13 (03) : 233 - 240
12345